PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
about
Role of the PD-1 pathway in the immune responseLeft Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure.Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma.Neopterin and beta-2 microglobulin relations to immunity and inflammatory status in nonischemic dilated cardiomyopathy patientsProgrammed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patientsUpregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153.Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis.Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.The heart of the matter: protection of the myocardium from T cellsSynthetic RORγt Agonists Enhance Protective Immunity.Fulminant Myocarditis with Combination Immune Checkpoint Blockade.A Century of Radiation Therapy and Adaptive ImmunityTreating atherosclerosis with regulatory T cells.A perspective on the impact of radiation therapy on the immune rheostat.T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates.Cardiovascular Toxicities Associated with Cancer Immunotherapies.[Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab].Cardiac Autoimmunity: Myocarditis.Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart MuscleCardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyTwo sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditisSmoldering myocarditis following immune checkpoint blockade.Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis.Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer.Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC.Immune checkpoint inhibitor-related myocarditis.Fibrinogen-like protein-2 causes deterioration in cardiac function in experimental autoimmune myocarditis rats through regulation of programmed death-1 and inflammatory cytokines.PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.Fatal myocarditis and rhabdomyolysis induced by nivolumab during the treatment of type B3 thymoma.Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for non-small cell lung cancer.Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.Lung cancer as a cardiotoxic state: a review.Cardiotoxicity of immune checkpoint inhibitors.
P2860
Q26828748-9121AB64-88C2-43AB-AE4F-20A800124A42Q27340146-F3FA6F3D-4FA9-4BC7-BD5A-89498A4C256AQ30641952-EF907F93-C110-446C-9A4E-72F02C1974F0Q34118314-DEC859A2-238C-4CA5-A38E-7AB3BAA011C0Q34173755-74C3113C-5424-4F5F-ACC1-8E026B6EBFBFQ34790920-7AA898F7-825D-4FD2-B930-6DAAA2133925Q35611631-5C90B14E-4C00-40F7-BAAA-4E0E7E5776E1Q36211501-556F936F-0A4A-4994-8709-8B5332F25224Q36259538-13462E78-3405-43FF-BE2E-ED188B4FD0D2Q37095348-0BE475C8-AFA6-4CC9-988D-994746A44B46Q37176323-A2BD75FF-B61F-4EC5-8D93-F8A60F7EE713Q37198750-DE43A393-7790-4060-9B4F-93EA48F37744Q37526761-B5899E29-DEEB-45DD-ADDF-381FB6AEAF0EQ37595462-594A4205-9233-4EEA-8427-C5409D49C501Q37747153-11917531-07C5-479F-821F-443E35968BE6Q38270134-AD22C2A4-DD23-4C6D-AF8E-F6C9F2ADF4DFQ38679488-128766F0-EB28-441C-8A50-8A9ED9B6E334Q38826175-27DD6038-12A8-4228-B321-285222476871Q39066825-6981C800-521A-4404-9ECF-A7E4A71647ABQ39144916-019B9C9D-D79F-45A3-80ED-01F0CF29DA0DQ40078647-AC4EB922-10DE-4949-A124-00D7CCC2668CQ40138726-F8A82959-481A-4937-90DF-2E854EC0E9B7Q41417860-3AC6A4DE-087E-414B-83DC-787478D2C144Q42354162-CAE32644-D369-41C6-A04E-56895C7CFCA5Q42649294-F2514D56-2414-4FD9-AF9D-77AF47ECD0E3Q47105402-D68650F6-161B-4698-81BE-14671AF129C6Q47148480-63948C15-B158-448E-8721-588518988418Q47160878-15833A7B-6C41-4563-B25E-3E79C119F857Q47162183-92FA924D-41FB-4251-BA7D-E8EF258A0BC7Q47224948-F5262677-1472-4D9E-88CB-6E4CFBB23C07Q47239900-88064E13-07BD-4752-B4BD-FCABBA63D3F0Q47553695-B25BFE57-BED0-4E84-993B-9A4CAF99FA24Q47633085-74291B3D-54A5-4115-B7F7-5A29850EA558Q47823401-E4E4726C-1FCB-4B2E-884C-6D6390759A5DQ48165202-52204E35-896B-4EFC-911B-CA84AF5AEE49Q48324118-34663A7B-34CF-45C7-B3C1-4AEC1E96E396Q51627654-682D37A7-8D71-452F-8F55-5BC8FEE86A09Q52641866-B46854DF-9CC4-4808-BAC9-2559438E349EQ53117997-DBA5F0DE-FDAC-437E-A366-5572A731C4C3Q55438414-7B0F5841-754F-4D28-B32D-069F651EC832
P2860
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
@ast
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
@en
type
label
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
@ast
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
@en
prefLabel
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
@ast
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
@en
P2093
P2860
P356
P1476
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.
@en
P2093
Andrew H Lichtman
Arlene H Sharpe
Margarite L Tarrio
Nir Grabie
P2860
P304
P356
10.4049/JIMMUNOL.1200389
P407
P577
2012-04-09T00:00:00Z